Type 2 Diabetes Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- A signed consent form (or assent form for those under 18 years old) must be completed before any study activities take place, in line with local rules — or an approved waiver of this requirement must be in place.
- People who received at least 1 day of teplizumab treatment through a Managed Access Program (MAP) (confirm with trial site).
Who may not be able to join:
- People who were already taking part in another interventional clinical trial on the date they started this study — meaning they were already receiving an experimental treatment or procedure being tested in a separate study that required following a specific research protocol rather than standard medical care.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 800-633-1610
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Participant demographics at teplizumab initiation; Participants' family history of T1D and autoimmune diseases; Presence of T1D susceptibility genes; Presence of T1D susceptibility genes; Participants' medical history
Can't join this trial?
Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.